Bridgewater Associates LP Reduces Stock Position in Integer Holdings Co. (NYSE:ITGR)

Bridgewater Associates LP trimmed its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 30.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,529 shares of the medical equipment provider’s stock after selling 1,559 shares during the quarter. Bridgewater Associates LP’s holdings in Integer were worth $468,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Blue Trust Inc. raised its position in Integer by 4.4% in the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock worth $220,000 after purchasing an additional 71 shares during the period. Arizona State Retirement System raised its holdings in shares of Integer by 0.9% in the fourth quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider’s stock worth $1,290,000 after buying an additional 84 shares during the period. HighPoint Advisor Group LLC lifted its stake in shares of Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 101 shares during the last quarter. Norden Group LLC lifted its stake in shares of Integer by 7.0% during the 4th quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider’s stock worth $221,000 after acquiring an additional 109 shares during the last quarter. Finally, Corient Private Wealth LLC grew its position in Integer by 6.4% in the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider’s stock valued at $261,000 after acquiring an additional 118 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ITGR. Benchmark boosted their target price on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Raymond James began coverage on shares of Integer in a research note on Friday, March 28th. They issued an “outperform” rating and a $145.00 target price on the stock. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. KeyCorp increased their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Truist Financial decreased their target price on Integer from $163.00 to $140.00 and set a “buy” rating for the company in a research report on Friday, April 11th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $146.00.

Integer Trading Up 0.7 %

ITGR opened at $116.99 on Friday. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 1.72 and a beta of 1.09. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36. The stock has a fifty day moving average price of $121.57 and a 200-day moving average price of $130.56.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. As a group, equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.